The AAV vector plasmids pXL3937-CMV-mSeAP, pGG2-CMV-Luc and pGG2-CMV-LacZ contain, respectively, the cDNA of a murine secreted alkaline phosphatase (mSeAP)[21], the luciferase gene and the cytosolic LacZ bacterial gene subcloned into an AAV plasmid backbone which has the ITRs of AAV2. with AAV2 encoding a murine secreted alkaline phosphatase (mSeAP). The transgene manifestation, vector biodistribution and cells transduction were analyzed by quantification of the mSeAP protein and real time PCR. The injection of polyinosinic acid and polylysine resulted in an increase of plasmatic mSeAP of 2- and 12-fold, respectively. Interestingly, polyinosinic acid pre-injection significantly reduced the neutralizing antibody titer raised against AAV2. == Conclusions == Our results show the pre-injection of polymers can improve the overall transduction effectiveness of systemically given AAV2 and reduce the humoral response against the capsid proteins. == Intro == Adeno-associated computer virus mediated gene transfer has a great potential due to its capacity to transduce a wide spectrum of both dividing and non-dividing Mouse monoclonal to beta Tubulin.Microtubules are constituent parts of the mitotic apparatus, cilia, flagella, and elements of the cytoskeleton. They consist principally of 2 soluble proteins, alpha and beta tubulin, each of about 55,000 kDa. Antibodies against beta Tubulin are useful as loading controls for Western Blotting. However it should be noted that levels ofbeta Tubulin may not be stable in certain cells. For example, expression ofbeta Tubulin in adipose tissue is very low and thereforebeta Tubulin should not be used as loading control for these tissues cell types. For example, common transduction of skeletal muscle tissue in adult mice and hamster after a single intravenous administration of recombinant adeno-associated computer virus has been explained[1],[2]. These results open new hopes for the treatment by gene therapy of neuromuscular diseases such as Duchenne muscular dystrophy (DMD). However, the broad tropism of the AAV vectors presents also a drawback since it precludes specificin vivotargeting. Another consequence when considering a gene therapy approach for a disorder such as DMD is definitely that because a majority of the diseased cells have to be transduced in order to have a therapeutic benefit, whole-body AAV transduction of muscle mass requires the injection of very large amounts of vectors. For human being application, this increases not only security concerns but it also represents a hurdle at the level of large scale production of rAAVs. One method to conquer both problems would be to find strategies able to increase the transduction efficiencyin vivo, without increasing the safety risks. Attempts to increase the transduction effectiveness or to improve the tropism have been done by using genetic capsid changes approaches. These include for example site-directed mutagenesis of surface-exposed tyrosine residues[3][5]and incorporation of focusing on peptides selected by Sanggenone C phage display on the surface of AAV capsids[6],[7]. On the other hand, to engineer gene vectors that target a given cells, random libraries of adeno-associated computer virus (AAV) can be generated by shuffling the capsid genes[8]. A few nongenetic strategies for enhancing the effectiveness of recombinant AAV have also been developed. Walters and co-workers for example have shown that incorporation of AAV2 inside a calcium phosphate co-precipitate enhances gene transfer to airway epithelia after intranasal instillation[9]. More recently, it was demonstrated that addition of cationic lipids to AAV2/9 improved the transduction effectiveness of the lung[10]. Covalent changes of the capsid by either polyethyleneglycol chains[11]or by HPMA copolymers have also been evaluated[12]. In the present work, we investigated two original non-genetic strategies to enhance thein vivoefficiency of AAV. For our study, we focused on AAV2 because among the currently used AAV Sanggenone C serotypes, it is the most analyzed and best characterized serotype, as well as the most used in medical tests. The strategies that we have analyzed here consisted in the pre-injection of cationic or anionic polymers a few minutes before intravenous infusion of the AAV2 viral particles. The anionic polymer which we focused on was polyinosinic acid (pI). This compound was chosen since Sanggenone C it has been previously reported to bind scavenger receptors and because it has been shown that an injection of pI prior to adenovirus administration results in enhanced transgene manifestation[13]. It was therefore of interest to test whether the pre-injection of pI could prevent illness by AAV2 of Kupffer cells or additional antigen showing cells, and thus, not only enhance the transduction of Sanggenone C additional cells but also reduce the humoral immune response against AAV2 capsid proteins. We have also evaluated the effect of pre- or co-injection of a series of cationic polymers, namely polylysines (pLys) with different examples of polymerization (dp). The rationale was that AAV2 uses cell membrane-associated heparan sulfate proteoglycan (HSPG) as its main binding receptor[14],[15]. This binding is definitely driven by electrostatic connection between bad HSPG and five positively charged amino acids[16]. Notably, the insertion of negatively charged peptides with this HSPG binding motif was shown to ablate HSPG binding, whereas positively charged peptides could restore the relationships[17]. Since polylysine is able to bind through electrostatic relationships to HSPG[18], we hypothesized that this polymer could alter the AAV biodistribution and transduction effectiveness. The experiments were conducted using a murine secreted alkaline phosphatase (mSeAP), whose production can be quantified in blood samples as well as on cells sections. Vector biodistribution was further evaluated in different tissues by real time PCR of the recombinant viral genomes. Our results show the pre-injection of polylysine resulted in a 5 to 12-collapse increase.